Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Hold
56,328
﹤0.01% 19
2025
Q4
$305K Sell
56,328
-225,308
-80% -$1.1M ﹤0.01% 20
2025
Q3
$1.13M Hold
281,636
0.03% 14
2025
Q2
$1.93M Hold
281,636
0.04% 13
2025
Q1
$3.58M Hold
281,636
0.09% 12
2024
Q4
$3.85M Buy
281,636
+225,308
+400% +$2.28M 0.09% 12
2024
Q3
$972K Buy
56,328
+1
+0% +$2 0.1% 21
2024
Q2
$88.8K Hold
56,327
0.01% 29
2024
Q1
$161K Hold
56,327
0.01% 31
2023
Q4
$163K Hold
56,327
0.01% 24
2023
Q3
$200K Hold
56,327
0.01% 24
2023
Q2
$369K Hold
56,327
0.01% 23
2023
Q1
$242K Buy
+56,327
New +$346K 0.01% 28

Other funds holding XCUR

Carlyle Group's XCUR Position: Q1 2026 in Review

Carlyle Group held its Exicure (XCUR) position steady in Q1 2026 at 56,328 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #19.

Carlyle Group first reported a position in XCUR in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.85M in Q4 2024. 18 funds tracked by Wall St. Rank hold XCUR as of Q1 2026.

  • Carlyle Group held 56,328 shares of Exicure worth $240K as of Q1 2026.
  • Carlyle Group left its Exicure share count unchanged in Q1 2026.
  • Exicure made up ﹤0.01% of Carlyle Group's portfolio in Q1 2026, its #19 holding.
  • Carlyle Group first reported a position in Exicure in Q1 2023 and has held it in 13 quarters since.
  • Carlyle Group's Exicure position peaked at $3.85M in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Exicure as of Q1 2026.

Based on Carlyle Group's 13F filing for Q1 2026, filed 8 May 2026.